EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 6,240.00
+120.00 (1.96%)
Jul 21, 2026, 3:30 PM KST
EASY BIO,Inc. Market Cap
EASY BIO,Inc. has a market cap or net worth of 202.46 billion as of July 20, 2026. Its market cap has increased by 14.18% in one year.
Market Cap
202.46B
Enterprise Value
324.96B
Revenue
490.70B
Ranking
n/a
PE Ratio
6.06
Stock Price
6,240.00
ChartMarket Cap Chart
Since June 5, 2020, EASY BIO,Inc.'s market cap has increased from 34.76B to 202.46B, an increase of 482.49%. That is a compound annual growth rate of 33.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 202.46B | 5.34% |
| Dec 30, 2025 | 192.21B | 37.78% |
| Dec 30, 2024 | 139.50B | 12.89% |
| Dec 28, 2023 | 123.58B | -10.06% |
| Dec 29, 2022 | 137.40B | -14.99% |
| Dec 30, 2021 | 161.64B | -23.75% |
| Dec 18, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 289.66B |
| SillaJen | 286.81B |
| Proteina | 265.95B |
| BINEX | 214.65B |
| GC Cell | 200.46B |
| Anterogen.Co.,Ltd. | 183.21B |
| HLB Therapeutics | 171.62B |
| JETEMA, | 165.93B |